The Role of Smart Devices and Mobile Application on the Change in Peak Vo2 in Patients With High Cardiovascular Risk: a Sub-Study of the Light Randomised Clinical Trial

dc.authorid Hayiroglu, Mert/0000-0001-6515-7349
dc.authorwosid Cillihayiroglu, Selin/Lxv-6985-2024
dc.authorwosid Cinar, Tufan/Abd-4630-2020
dc.authorwosid Hayıroğlu, Mert İlker/Aex-7656-2022
dc.authorwosid Şaylık, Faysal/Gqq-3347-2022
dc.contributor.author Hayiroglu, Mert Ilker
dc.contributor.author Cinar, Tufan
dc.contributor.author Hayiroglu, Selin Cilli
dc.contributor.author Saylik, Faysal
dc.contributor.author Uzun, Mehmet
dc.contributor.author Tekkesin, Ahmet Ilker
dc.date.accessioned 2025-05-10T17:21:40Z
dc.date.available 2025-05-10T17:21:40Z
dc.date.issued 2023
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Hayiroglu, Mert Ilker; Tekkesin, Ahmet Ilker] Dr Siyami Ersek Thorac & Cardiovasc Surg Training, Dept Cardiol, Istanbul, Turkiye; [Cinar, Tufan; Uzun, Mehmet] Haydarpasa Sultan II Abdulhamid Han Training & Res, Dept Cardiol, Istanbul, Turkiye; [Hayiroglu, Selin Cilli] Marmara Univ, Dept Rheumatol, Fac Med, Istanbul, Turkiye; [Saylik, Faysal] Van Training & Res Hosp, Dept Cardiol, Van, Turkiye en_US
dc.description Hayiroglu, Mert/0000-0001-6515-7349 en_US
dc.description.abstract BackgroundThis investigation aims to assess the influence of a mobile application and smart devices on cardiopulmonary exercise testing (CPET) over a one-year period in individuals who have high risk for cardiovascular disease. Methods: This is a post-hoc subgroup analysis of Lifestyle Intervention Using Mobile Technology in Patients with High Cardiovascular Risk: A Pragmatic Randomised Clinical Trial (LIGHT). In the intervention plus standard care standard standard care arms, 138 and 103 patients were recruited, respectively. The 1-year VO2 measurements were adjusted to the baseline VO2 measurements as the study's endpoint. VO2 measurements were taken for each subject during the randomisation and final CPET examinations. Results The intervention plus standard care improved VO2 measurements by 1.1 (adjusted treatment effect 1.1, 95% confidence interval (CI): 0.8, 1.4, p < 0.001) compared to standard care following 1-year follow-up. Conclusion At a 1-year follow-up, the smart device and mobile application technologies increased VO2 measurements in individuals with high cardiovascular risk compared to conventional treatment alone. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1080/00015385.2023.2223005
dc.identifier.endpage 1005 en_US
dc.identifier.issn 0001-5385
dc.identifier.issn 1784-973X
dc.identifier.issue 9 en_US
dc.identifier.pmid 37318090
dc.identifier.scopusquality Q3
dc.identifier.startpage 1000 en_US
dc.identifier.uri https://doi.org/10.1080/00015385.2023.2223005
dc.identifier.uri https://hdl.handle.net/20.500.14720/10481
dc.identifier.volume 78 en_US
dc.identifier.wos WOS:001008456900001
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Taylor & Francis Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Mobile Application en_US
dc.subject Cardiopulmonary Exercise Test en_US
dc.subject Digital Health Intervention en_US
dc.title The Role of Smart Devices and Mobile Application on the Change in Peak Vo2 in Patients With High Cardiovascular Risk: a Sub-Study of the Light Randomised Clinical Trial en_US
dc.type Article en_US
dspace.entity.type Publication

Files